These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23664995)

  • 1. Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adults.
    Collins AM; Batrawy SE; Gordon SB; Ferreira DM
    Vaccine; 2013 Aug; 31(35):3469-72. PubMed ID: 23664995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya.
    Laine C; Mwangi T; Thompson CM; Obiero J; Lipsitch M; Scott JA
    Infect Immun; 2004 Jun; 72(6):3331-5. PubMed ID: 15155637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
    Chen A; Mann B; Gao G; Heath R; King J; Maissoneuve J; Alderson M; Tate A; Hollingshead SK; Tweten RK; Briles DE; Tuomanen EI; Paton JC
    Clin Vaccine Immunol; 2015 Oct; 22(10):1079-89. PubMed ID: 26245351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
    Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
    Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
    Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
    Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia.
    Kataoka K; Fujihashi K; Oma K; Fukuyama Y; Hollingshead SK; Sekine S; Kawabata S; Ito HO; Briles DE; Oishi K
    Infect Immun; 2011 Jul; 79(7):2819-28. PubMed ID: 21536790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury.
    Salha D; Szeto J; Myers L; Claus C; Sheung A; Tang M; Ljutic B; Hanwell D; Ogilvie K; Ming M; Messham B; van den Dobbelsteen G; Hopfer R; Ochs MM; Gallichan S
    Infect Immun; 2012 Jun; 80(6):2212-20. PubMed ID: 22473606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination With the Commensal
    Shekhar S; Åmdal HA; Petersen FC
    Front Immunol; 2021; 12():676488. PubMed ID: 33953733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae.
    Denoël P; Philipp MT; Doyle L; Martin D; Carletti G; Poolman JT
    Vaccine; 2011 Jul; 29(33):5495-501. PubMed ID: 21624422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children.
    Zhang Q; Choo S; Finn A
    Infect Immun; 2002 Oct; 70(10):5363-9. PubMed ID: 12228260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children.
    Ditse Z; Adrian PV; Kuwanda L; Madhi SA
    Vaccine; 2013 Sep; 31(40):4421-7. PubMed ID: 23845819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage.
    Holmlund E; Quiambao B; Ollgren J; Nohynek H; Käyhty H
    Vaccine; 2006 Jan; 24(1):57-65. PubMed ID: 16115703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
    Arévalo MT; Xu Q; Paton JC; Hollingshead SK; Pichichero ME; Briles DE; Girgis N; Zeng M
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):346-51. PubMed ID: 19291171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.
    Kong IG; Sato A; Yuki Y; Nochi T; Takahashi H; Sawada S; Mejima M; Kurokawa S; Okada K; Sato S; Briles DE; Kunisawa J; Inoue Y; Yamamoto M; Akiyoshi K; Kiyono H
    Infect Immun; 2013 May; 81(5):1625-34. PubMed ID: 23460513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal conjugate vaccine is immunogenic in lung fluid of HIV-infected and immunocompetent adults.
    Gordon SB; Kayhty H; Molyneux ME; Haikala R; Nurkka A; Musaya J; Zijlstra EE; Lindell D; French N
    J Allergy Clin Immunol; 2007 Jul; 120(1):208-10. PubMed ID: 17544493
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonspecificity of assaying for IgG antibody to pneumolysin in circulating immune complexes as a means to diagnose pneumococcal pneumonia.
    Musher DM; Mediwala R; Phan HM; Chen G; Baughn RE
    Clin Infect Dis; 2001 Feb; 32(4):534-8. PubMed ID: 11181114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung fluid immunoglobulin from HIV-infected subjects has impaired opsonic function against pneumococci.
    Eagan R; Twigg HL; French N; Musaya J; Day RB; Zijlstra EE; Tolmie H; Wyler D; Molyneux ME; Gordon SB
    Clin Infect Dis; 2007 Jun; 44(12):1632-8. PubMed ID: 17516409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization.
    Greene CJ; Marks LR; Hu JC; Reddinger R; Mandell L; Roche-Hakansson H; King-Lyons ND; Connell TD; Hakansson AP
    Infect Immun; 2016 Jun; 84(6):1693-1703. PubMed ID: 27001538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin.
    García-Suárez Mdel M; Cima-Cabal MD; Flórez N; García P; Cernuda-Cernuda R; Astudillo A; Vázquez F; De los Toyos JR; Méndez FJ
    Infect Immun; 2004 Aug; 72(8):4534-40. PubMed ID: 15271913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients.
    Huo Z; Spencer O; Miles J; Johnson J; Holliman R; Sheldon J; Riches P
    Vaccine; 2004 Mar; 22(9-10):1157-61. PubMed ID: 15003643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.